Home
/
ALX ONCOLOGY HOLDINGS INC
/
Financials
/
Quarterly
ALX ONCOLOGY HOLDINGS INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that ALX ONCOLOGY HOLDINGS INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2021
Sep 30, 2020
$1.18M
Nov 12, 2021
Q2
2021
Jun 30, 2020
$527.0K
Aug 12, 2021
Q1
2021
Mar 31, 2020
$655.0K
May 17, 2021
Q3
2020
Sep 30, 2019
$1.26M
Nov 12, 2020
Q2
2020
Jun 30, 2019
$1.30M
Aug 27, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($22.14M)
Nov 7, 2025
Q3
2025
Jun 30, 2025
($25.95M)
Nov 7, 2025
Q2
2025
Jun 30, 2025
($25.95M)
Aug 12, 2025
Q2
2025
Mar 31, 2025
($30.75M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($30.75M)
May 8, 2025
Q3
2025
Mar 31, 2025
($30.75M)
Nov 7, 2025
Q3
2025
Sep 30, 2024
($30.71M)
Nov 7, 2025
Q3
2025
Jun 30, 2024
($39.40M)
Nov 7, 2025
Q2
2025
Jun 30, 2024
($39.40M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($35.58M)
May 8, 2025
Q2
2025
Mar 31, 2024
($35.58M)
Aug 12, 2025
Q3
2025
Mar 31, 2024
($35.58M)
Nov 7, 2025
Q3
2024
Sep 30, 2023
($50.99M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($34.16M)
Aug 12, 2024
Q3
2024
Jun 30, 2023
($34.16M)
Nov 7, 2024
Q2
2024
Mar 31, 2023
($30.18M)
Aug 12, 2024
Q3
2024
Mar 31, 2023
($30.18M)
Nov 7, 2024
Q1
2024
Mar 31, 2023
($30.18M)
May 9, 2024
Q3
2023
Sep 30, 2022
($35.32M)
Nov 13, 2023
Q3
2023
Jun 30, 2022
($32.92M)
Nov 13, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($22.53M)
Nov 7, 2025
Q2
2025
Jun 30, 2025
($26.65M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($31.82M)
May 8, 2025
Q3
2025
Sep 30, 2024
($32.57M)
Nov 7, 2025
Q2
2025
Jun 30, 2024
($41.53M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($37.76M)
May 8, 2025
Q3
2024
Sep 30, 2023
($53.28M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($36.78M)
Aug 12, 2024
Q1
2024
Mar 31, 2023
($32.20M)
May 9, 2024
Q3
2023
Sep 30, 2022
($36.68M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($33.79M)
Aug 10, 2023
Q1
2023
Mar 31, 2022
($24.75M)
May 11, 2023
Q3
2022
Sep 30, 2021
($24.58M)
Nov 8, 2022
Q2
2022
Jun 30, 2021
($16.30M)
Aug 8, 2022
Q1
2022
Mar 31, 2021
($14.21M)
May 9, 2022
Q3
2021
Sep 30, 2020
($9.81M)
Nov 12, 2021
Q2
2021
Jun 30, 2020
($10.79M)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($5.24M)
May 17, 2021
Q3
2020
Sep 30, 2019
($3.03M)
Nov 12, 2020
Q2
2020
Jun 30, 2019
($4.19M)
Aug 27, 2020